IMS QUIZ on Perimenopausal Bleeding, Bangalore Menopause Society marks

Similar documents
Gynecologic Decision Making Based on Sonographic Findings

One of the commonest gynecological cancers,especially in white Americans.

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

Endometrial Cancer. Incidence. Types 3/25/2019

Endometrial cancer. Szabolcs Máté MD. I. St. Department of Obstetrics and Gyneacology.

New Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%

Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE

3/25/2019. Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates

Female Genital Tract Lab. Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan

Endometrial line thickness in different conditions.

Management of Endometrial Hyperplasia

5 Mousa Al-Abbadi. Ola Al-juneidi & Obada Zalat. Ahmad Al-Tarefe

CLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION

Staging and Treatment Update for Gynecologic Malignancies

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)

Index. B Bilateral salpingo-oophorectomy (BSO), 69

STUMPed for a Diagnosis Contemporary Management of Uterine Sarcomas

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)


Gynaecological Oncology Cases

Menstrual Disorders & Ambulatory Gynaecology

JMSCR Vol 05 Issue 06 Page June 2017

Unexpected Gynecologic Findings at Laparotomy. Susan A. Davidson, MD University of Colorado, Denver School of Medicine

29 Cancer of the Uterine Corpus

UTERINE SARCOMA EXAMPLE OF A UTERINE SARCOMA USING PROPOSED TEMPLATE

PORTEC-4. Patient seqnr. Age at inclusion (years) Hospital:

Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru

ARRO Case: Early-stage Endometrial Cancer

Quiz. b. 4 High grade c. 9 Unknown

It is a malignancy originating from breast tissue

Management of Endometrial Hyperplasia

Female genital tract II.


C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

Case 1. Gynaecology Case Presentation. Objectives. Disclosures 22/10/ year old female Clinical history: Assess right ovarian cyst

Menorrhagia Update. Simon Edmonds Middlemore Hospital Ascot Central Women s Clinic Auckland

Pathology of Ovarian Tumours. Dr. Jyothi Ranganathan MD ( Path) AFMC Pune PDCC (Cytopathology) PGI Chandigarh

Case Scenario 1. History

Atypical Hyperplasia/EIN

Medical Management of Fibroids Esmya. Dr Paula Briggs Consultant in Sexual and Reproductive Health

Cynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital

Ovarian Lesion Benign vs Malignant?

NAACCR Webinar Series /7/17

Frequency of menses. Duration of menses 3 days to 7 days. Flow/amount of menses Average blood loss with menstruation is 60-80cc.

Pathology of the female genital tract

Heavy Menstrual Bleeding. Mr Nick Nicholas MD FRCOG Grad Dip Law. Consultant Gynaecologist

What is endometrial cancer?

PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT

Case Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue

Abnormal uterine bleeding:

Fibroid mapping. Haitham Hamoda MD FRCOG Consultant Gynaecologist, Subspecialist in Reproductive Medicine & Surgery King s College Hospital

bleeding Studies naar de diagnostiek van endom triumcarcinoom bij vrouwen met postm nopauzaal bloedverlies. Studies on the

Port-Site Metastases After Robotic Surgery for Gynecologic Malignancy

Page # 1. Endometrium. Cellular Components. Anatomical Regions. Management of SIL Thomas C. Wright, Jr. Most common diseases:

X-Plain Ovarian Cancer Reference Summary

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

Oppgave: MED5600_OPPGAVE04_V18_ORD

Updates in Gynecologic Oncology. Todd Boren, MD Gynecologic Oncologist Chattanooga s Program in Women s Oncology Sept 8 th, 2018

Gynaecology NSSG (Lancs & South Cumbria) Uterine Cancer Guidelines (V4.0)

Endometrial polyp icd-10

Gynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure:

Gynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health

UTERINE SARCOMAS CURRENT THERAPEUTIC OPTIONS

Cervical cancer presentation

Excessive menstrual blood loss

Endometrial cancer. Cathrine Holland

Conflicts 10/5/2016. Abnormal Uterine Bleeding. Objectives Review diagnosis and updated nomenclature. Management options for acute and chronic AUB.

Kieran Sultan, PGY4 Penrose St. Francis Hospital

Monica Dandapani, 1 Brandon-Luke L. Seagle, 1 Amer Abdullah, 1 Bryce Hatfield, 2 Robert Samuelson, 1 and Shohreh Shahabi 3. 1.

Endometrial stromal tumor in woman A rare presentation

Summary CHAPTER 1. Introduction

The Good Uterine Sarcomas: What Do You Need to Know

Gynecologic Malignancies. Kristen D Starbuck 4/20/18

North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer

GENERAL DATA. Sex : female Age : 40 years old Marriage status : married

Chapter 100 Gynecologic Disorders

Definition of Synoptic Reporting

Michael G. Kelly, MD Gynecologic Oncologist University of Colorado Cancer Center

GYNECOLOGIC MALIGNANCIES: Ovarian Cancer

Ovaries: In Sickness and Health. Mr N Pisal Consultant Gynaecologist The Portland Hospital

5/5/2010 FINANCIAL DISCLOSURE. Abnormal Uterine Bleeding. Is This A Problem? About me % of visits to gynecologist

Breast Cancer Risk Assessment and Prevention

Top Tips for Gynaecological Ultrasound. Catherine Kirkpatrick Consultant Sonographer Dublin Oct 2018

Staging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion

Endometrial Stromal Sarcoma

Heavy menstrual bleeding: assessment and management

Ovarian Cancer Causes, Risk Factors, and Prevention

Pre-operative Evaluation and Implications

Gynecologic Oncologist. Surgery Chemotherapy Radiation Therapy Hormonal Therapy Immunotherapy. Cervical cancer

Molly A. Brewer DVM, MD, MS Chair and Professor Department of Obstetrics and Gynecology University of Connecticut School of Medicine

JMSCR Vol 05 Issue 11 Page November 2017

Gynaecology Cancer Red Flags. Dr Dina Bisson Consultant Obstetrician and Gynaecologist Southmead Hospital North Bristol NHS Trust 27 April 2017

Triage of Ovarian Masses. Andreas Obermair Brisbane

Case Report Serous Ovarian Carcinoma Recurring as Malignant Mixed Mullerian Tumor

Breast Cancer. Dr. Andres Wiernik 2017

Janjira Petsuksiri, M.D

L/O/G/O. Ovarian Tumor. Xiaoyu Niu Obstetrics and Gynecology Department Sichuan University West China Second Hospital

Endometrial adenocarcinoma icd 10 code

UTERINE LEIOMYOSARCOMA. About Uterine leiomyosarcoma

3/25/ % arise from coelomic epithelium

Transcription:

IMS QUIZ on Perimenopausal Bleeding, Bangalore Menopause Society 19.11.2017 100 marks Fill in the blanks 20 marks 1. Gestrinone is a synthetic derivative of 19-nortestosterone steroid nucleus 2. Risk of Endometrial Hyperplasia without atypia progressing to cancer in 20 years...less than 5 % 3. Revised World Health Organization (WHO) classification of Endometrial Hyperplasia in 2014 is- Hyperplasia without atypia and Atypical Hyperplasia 4.WHO 1994 Classification of Endometrial Hyperplasia - Simple Hyperplasia with and without atypia Complex Hyperplasia with and without atypia 5. The EIN diagnostic scheme (2003) comprises of- Benign, Premalignant & Malignant lesions 6. Percentage of women with a negative biopsy with pipelle sampling found to have endometrial hyperplasia-- 2% 7. Risk of endometrial cancer when endometrial thickness is <3-4 mm in postmenopausal women--< 1% 8. Endometrial cutoff below which endometrial hyperplasia is not seen, especially in PCOS women -<7 mm 9. Percentage of pts in whom DD and C can miss out on endometrial pathology--10% 10. Palpable nodule in the umbilicus due to metastasis from a pelvic or abdominal primary--sister Mary Joseph sign or Lymph node State True or False 20 marks 11. BLC-2 is a Biomarker which is being studied in the diagnosis of endometrial hyperplasia (T) 12. Women taking aromatase inhibitors (such as anastrozole, exemestane and letrozole) should be informed that these medications are known to increase the risk of endometrial hyperplasia and cancer (F) Do not increase risk 13. Hysteroscopy is more useful in diagnosing cancer than hyperplasia (T) 14. LNG IUS is recommended to reduce polyp formation with Tamoxifen (F) 15. Classical Cesarean section is not a contraindication for Endometrial Ablation. (F) It is contraindicated, along with Transmural myomectomy open or laparoscopic, as myometrial thinning from prior surgery can cause damage to surrounding viscera 16. In a woman with Endometrial Hyperplasia without atypia, Pipelle sampling is recommended every 3 months until 2 negative samples are obtained. (F) Every 6 months 17. Leiomyoma has a higher arterial density than the surrounding normal myometrium. (F) Lower density 18. Progesterone is the critical mitogen for uterine leiomyoma growth and development. (T) 19. A submucous leiomyoma has only one feeding vessel. (F) A submucous fibroid has many feeder vessels from the inner myometrium unlike an endometrial polyp which has only one feeding artery. 20. Saline can be used as the distending medium for endometrial ablation with monopolar cautery. (F) No. Only hypo-osmolar, non-electrolyte solutions like Glycine What are the following acronyms? 10 marks

21. PTEN---phosphatase and tensin homolog 22. PATSS---Post Ablation Tubal Sterilization Syndrome 23. CASH study---cancer and steroid hormone study 24. PORTEC study ---Post-Op Radiation Therapy in Endometrial Carcinoma 25. CUSA ---Cavitron Ultrasonic Surgical Aspirator Mention the recommended dosage of the following in Fibroid management: 10 marks 26. Mifepristone.2.5-10mgs daily for 3-6 months 27. Ulipristal Acetate.5-10 mg tablets orally for 3 months 28. Tranexamic acid...650 mgs 2 tabs orally tid for 5 days 29. Leuprolide acetate.3.75mgs IM monthly for 3-6 months or 11.25mgs IM once in 3 months 30. Traditional Add-Back therapy...mpa 2.5mg + CEE 0.3mg daily for 3-6 months Pick the appropriate answer 30 marks 31. A 50 year old woman with Breast cancer, on Tamoxifen since 4 years comes to the clinic with a complaint of postmenopausal bleeding. TVS shows the endometrium to be 4 mm thick. You will.. a. Reassure the patient b. Rescan after 6 months c. Rescan after 3 months d. Do Hysteroscopy and biopsy 32. The following are true for Tamoxifen except a. Tamoxifen significantly increases the risk of endometrial cancer in postmenopausal women b. Tamoxifen is a SERM c. Tamoxifen increases the risk of uterine sarcoma d. Tamoxifen significantly increases the risk of endometrial cancer in premenopausal women 33. The following are features of Type 1 Endometrial ca except: a. They are estrogen dependent b. Well differentiated c. ER/PR positive d. PTEN mutation negative PTEN mutation positive 34. Adenocarcinoma uterus along with sarcoma of the uterus is known as: a. Homologous sarcoma b. Leiomyoblastoma

c. Malignant Mixed Mullerian Tumour d. Heterologous sarcoma 35. A perimenopausal patient presents with menorrhagia. On P/V/R she has a right adnexal mass, firm, regular & mobile. USG showed a solid mass in the right ovary 8 x 8 cm in size. Left ovary is normal. The Endometrial biopsy showed Hyperplasia. The most probable diagnosis is a. Fibroma ovary b. Granulosa cell tumour c. Brenner Tumour d. Struma ovarii 36. A 47 year old patient comes with menorrhagia. On P/V/R uterus is bulky, regular & mobile. Bilateral adnexae are free. USG pelvis reveals a bulky uterus with ET of 16mm. The MRI was reported as < 40% of the myometrium was involved. The endometrial sampling came as Endometrioid cancer Grade 3. The correct management will be a. TAH with BSO b. TAH with PLND c. TAH, BSO with Para-aortic lymphadenectomy d. TAH, BSO, PLND, Para-aortic node dissection, Omentectomy 37. The following syndromes are associated with Gynec cancer except one a. Peutz Jeghers syndrome b. Lynch Syndrome c. Cowden Syndrome d. Fanconi Sydrome 38. The theory of incessant ovulation as a cause of malignancy was proposed by a. M.D.Anderson b. M.F.Fathalla c. Goldstein d. Blumenthal 39. A 55 year old woman with postmenopausal bleeding underwent endometrial sampling. The HPE report came as Serous endometrial carcinoma, Grade 1. MRI was reported as less than 50% myometrial invasion- Stage 1A. What is the correct surgical procedure? a. TAH with BSO b. TAH with BSO and PLND c. TAH with BSO, PLND, Para-aortic lymphadenectomy and Omentectomy d. Wertheim s, BSO and Omentectomy 40. A 56 year old woman presents with postmenopausal bleeding. An endometrial pipelle sampling reveals Endometrioid Adenocarcinoma. MRI is done which shows uterine myometrial invasion less than 50% and enlarged pelvic lymph nodes. What is the stage?

a. Stage 2 b. Stage 3c 1 c. Stage 3 b d. Stage 3 c 2 41. Growth on cervix < 4cms in greatest diameter with parametrial involvement not extending to the pelvic wall with unilateral hydronephrosis. What is the Stage? a. Stage 2 b. Stage 3 c. Stage 4 d. Stage 1 42. Carcinoma is confined to the cervix with a stromal invasion of depth <3 mm and a linear extent of <7 mm with involvement of lympho-vascular spaces. Stage is a. Stage 1a1 b. Stage 1a2 c. Stage 2a d. Stage 2b LVS involvement does not change the staging 43. After removal, Endocervical polyps may recur in a. 1-2% of cases b. 3-4 % of cases c. 6-15% of cases d. 20-25% of cases 44. 2nd Generation methods of endometrial ablation include all of the following except one a. TCRE b. Thermal Balloon c. Cryo-ablation d. Microwave ablation 45. Post-Embolization syndrome typically lasts for a. 2-7 days b. 12-15 days c. 17-22 days d. 24-30 days Describe in one sentence 6 marks 46. Myomatous Erythrocytosis syndrome: Excessive erythropoietin is produced by the kidneys or by the fibroids themselves 47. Pseudo-Meigs Syndrome: Ascites and pleural effusion associated with large benign fibroids or ovarian cysts due to discordancy between arterial supply and lymphatic and venous drainage from the leiomyomas 48. Reed s Syndrome: Reed s syndrome is an autosomal dominant genetic condition with multiple cutaneous and uterine leiomyomatosis and a predilection for Renal Cancer due to mutations in the fumarate hydratase gene Give reasons: 4 marks 49. Why are GnRH analogues not recommended before UAE for fibroids? Because they decrease the vascularity and make UAE less effective 50. Why UAE is not recommended in Fibroids who have had prior Salpingectomy or Salpingo-oophorectomy? Because the arterial anatomy is altered -----------------------------------------------------------------------------------------------